CRDL Stock Analysis: Buy, Sell, or Hold?
CRDL - Cardiol Therapeutics Inc. Class A Common Shares
$1.05
0.02 (1.94%)
▲
5d:
-2.78%
30d:
-23.36%
90d:
-0.94%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CRDL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRDL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRDL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRDL is currently trading at $1.05, which is considered oversold relative to its 30-day fair value range of $1.11 to $1.33.
Technical Outlook: Technically, CRDL is in a uptrend. The price is currently testing key support at $1.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRDL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.23 (+588.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRDL is in a uptrend. The price is currently testing key support at $1.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRDL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.23 (+588.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.11 -
$1.33
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 588.6% below Wall St target ($7.23)
Trading Range Analysis
30-Day Trading Range
$1.11 -
$1.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.22
Current Trend
Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.75
Wall Street Target
$7.23
(+588.6%)
Share & Embed Analysis
Last updated: June 16, 2026 8:42 AM ET
Data refreshes hourly during market hours. Next update: 9:42 AM
Data refreshes hourly during market hours. Next update: 9:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 58 HOLD |
